04:09 PM EDT, 05/20/2024 (MT Newswires) -- Marc Lustig, 10% Owner, Director, on May 14, 2024, executed a purchase for 902,935 shares in Briacell Therapeutics ( BCTX ) for $2,000,001. Following the Form 4 filing with the SEC, Lustig has control over a total of 2,542,935 shares of the company, with 2,542,935 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1610820/000149315224020660/xslF345X03/ownership.xml

Price: 1.7600, Change: +0.27, Percent Change: +18.12